Biotalys NV Statistics

Total Valuation

Biotalys NV has a market cap or net worth of EUR 118.03 million. The enterprise value is 100.24 million.

Market Cap	118.03M
Enterprise Value	100.24M

Important Dates

The next estimated earnings date is Wednesday, August 20, 2025.

Earnings Date	Aug 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Biotalys NV has 37.47 million shares outstanding. The number of shares has increased by 5.28% in one year.

Current Share Class	n/a
Shares Outstanding	37.47M
Shares Change (YoY)	+5.28%
Shares Change (QoQ)	+6.86%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	5.39%
Float	12.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	4.28
P/TBV Ratio	4.37
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.60
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.85

Financial Position

The company has a current ratio of 5.50, with a Debt / Equity ratio of 0.18.

Current Ratio	5.50
Quick Ratio	4.95
Debt / Equity	0.18
Debt / EBITDA	n/a
Debt / FCF	-0.38
Interest Coverage	-85.94

Financial Efficiency

Return on equity (ROE) is -49.60% and return on invested capital (ROIC) is -26.31%.

Return on Equity (ROE)	-49.60%
Return on Assets (ROA)	-23.00%
Return on Invested Capital (ROIC)	-26.31%
Return on Capital Employed (ROCE)	-42.19%
Revenue Per Employee	n/a
Profits Per Employee	-209,333
Employee Count	63
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +3.92% in the last 52 weeks. The beta is 0.89, so Biotalys NV's price volatility has been lower than the market average.

Beta (5Y)	0.89
52-Week Price Change	+3.92%
50-Day Moving Average	3.26
200-Day Moving Average	3.15
Relative Strength Index (RSI)	47.37
Average Volume (20 Days)	16,520

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-13.49M
Pretax Income	-13.15M
Net Income	-13.19M
EBITDA	-12.35M
EBIT	-13.49M
Earnings Per Share (EPS)	-0.40

Full Income Statement

Balance Sheet

The company has 22.64 million in cash and 4.85 million in debt, giving a net cash position of 17.79 million or 0.47 per share.

Cash & Cash Equivalents	22.64M
Total Debt	4.85M
Net Cash	17.79M
Net Cash Per Share	0.47
Equity (Book Value)	27.61M
Book Value Per Share	0.74
Working Capital	21.47M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -12.65 million and capital expenditures -115,000, giving a free cash flow of -12.77 million.

Operating Cash Flow	-12.65M
Capital Expenditures	-115,000
Free Cash Flow	-12.77M
FCF Per Share	-0.34

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Biotalys NV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.28%
Shareholder Yield	-5.28%
Earnings Yield	-11.17%
FCF Yield	-10.82%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a